Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gliflozin effect on rheumatic mitral regurgitation assessed by speckle tracking echocardiography
PACTR202511489850900Not yet recruiting
- Sponsor
- Assiut University
- Start
- Apr 2026
- Countries
- 1
01
Overview
Open-label trial in rheumatic heart disease (RHD) and mitral regurgitation (MR) (2 arms), sponsored by Assiut University. Primary endpoint: Effect on left atrial and left ventricular strain parameters. Planned start Apr 2026; status: not yet recruiting.
02
Conditions
rheumatic heart disease (RHD)mitral regurgitation (MR)
Beyond the preview
Go deeper on PACTR202511489850900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202511489850900.